California Launches $429 Million in New Stem Cell/Gene Therapy Plans, Striving for Bigger Impact plus Speeding Commercialization
Action comes as Trump administration tightens federal research funding
SACRAMENTO, Ca. -- California’s ambitious stem cell and gene therapy agency approved sweeping new plans this morning as it searches for greater success in developing cures and treatments for afflictions ranging from autism to heart disease.
The effort came as the agency said investment in cell and gene therapy has “flatlined” and federal funding for biom…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.